The Analyst Landscape: 5 Takes On TScan Therapeutics
The Analyst Landscape: 5 Takes On TScan Therapeutics
分析师视角：对TScan Therapeutics的5个看法
The standing of TScan Therapeutics among...Ratings for TScan Therapeutics (NASDAQ:TCRX) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，5位分析师对TScan Therapeutics（纳斯达克：TCRX）的评级展示了看好和看淡的不同观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们近期评级的汇总视图，展示了过去30天的情绪变化，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $12.6, a high estimate of $15.00, and a low estimate of $11.00. Holding firm without variation, the current average remains at the previous average price target.
分析师通过对12个月价格目标的评估提供更深入的见解，显示平均目标为12.6美元，高估为15.00美元，低估为11.00美元。 当前平均值保持不变，仍然是之前的平均价格目标。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
The standing of TScan Therapeutics among...
通过对最近分...
登录免费看全文
登录/注册
资讯热榜
更新时间